Incidence of Advanced Adenomas of the Rectosigmoid Colon Three Years and Five Years After Negative Flexible Sigmoidoscopy in 4010 Patients

被引:0
|
作者
Williamson B. Strum
机构
[1] Scripps Clinic,The Division of Gastroenterology
[2] La Jolla,undefined
来源
关键词
colon adenomas; flexible sigmoidoscopy; cancer screening;
D O I
暂无
中图分类号
学科分类号
摘要
Flexible sigmoidoscopy is recommended for persons at average risk for colorectal cancer. A follow-up is advised in 3 to 5 years, although the outcomes are not well established. We designed a large, prospective study of an unselected population to measure the incidence of advanced adenomas at flexible sigmoidoscopy 3 and 5 years after an initial negative examination. Adenomas were considered advanced if they were villous, tubulovillous, high-grade dysplasia, adenocarcinoma, or ≥10 mm in size. We evaluated 8121 patients referred for flexible sigmoidoscopy and 4010 met the inclusion criteria. Group 1 had flexible sigmoidoscopy between 3 and 4 years and Group 2 between 5 and 6 years after a negative examination. Group 1 included 1300 patients with an incidence rate for advanced adenomas of 0.9% (12/1300) and Group 2 included 2710 patients with an incidence rate for advanced adenomas of 1.1% (30/2710). When the two group were subdivided by the presence or absence of a family history of a first-degree relative with sporadic colorectal cancer, the incidence rates for advanced adenomas between the populations were not different. Our data indicate incidence rates of 0.9 and 1.1% for advanced adenomas at flexible sigmoidoscopy 3 and 5 years, respectively, after a negative flexible sigmoidoscopy, with no impact from a family history.
引用
收藏
页码:2278 / 2283
页数:5
相关论文
共 35 条
  • [21] Incidence of First Cardiovascular Event in Spanish Patients with Chronic Inflammatory Rheumatic Diseases. Prospective Data After Five Years of Follow Up
    Auxiliadora Martin-Martinez, Maria
    Castaneda, Santos
    Sanchez-Alonso, Fernando
    Garcia-Gomez, Carmen
    Gonzalez Juanatey, Carlos
    Angeles Belmonte-Lopez, M.
    Tornero-Molina, Jesus
    Santos-Rey, Jose
    Olga Sanchez-Gonzalez, Carmen
    Moreno, Estefania
    del Puerto Moreno-Gil, Maria
    Cobo-Ibanez, Tatiana
    Antonio Pinto-Tasende, Jose
    Babio-Herraez, Jesus
    Bonilla, Gema
    Juan-Mas, Antonio
    Manero-Ruiz, Francisco
    Romera-Baures, Montserrat
    Bachiller-Corral, Javier
    Chamizo-Carmona, Eugenio
    Calvo-Catalan, Javier
    Sanmarti, Raimon
    Erausquin-Arruabarrena, Celia
    Garcia-Vicuna, Rosario
    Barbadillo, Carmen
    Ros-Exposito, Sergio
    Isabel Turrion, Ana
    Jose Gonzalez-Fernandez, M.
    Miguel Senabre, Jose
    Martinez-Pardo, Silvia
    Ruibal-Escribano, Ana
    Giner-Serret, Emilio
    Berzosa-Sola, Elisabet
    Martinez-Barrio, Julia
    Pagan, Encarnacion
    Enriqueta-Peiro, M.
    Bustabad-Reyes, Sagrario
    Erra-Duran, Alba
    Gonzalez Alvarez, Beatriz
    Cruz Valenciano, Ana
    Rivera-Redondo, Javier
    Moreno Ramos, Manuel
    Rodriguez Montero, Sergio
    Morcillo-Valle, Mercedes
    Teresa Navio, Maria
    Galindo-Izquierdo, Maria
    Riera-Soler, Manuel
    Fiter, Jordi
    Llorca, Javier
    Angel Gonzalez-Gay, Miguel
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [22] Characteristics and probability of survival for patients with advanced melanoma who live five or more years after initial treatment with immune checkpoint blockade (ICB).
    Loo, Kimberly
    Goldman, Debra A.
    Panageas, Katherine
    Callahan, Margaret K.
    Chapman, Paul B.
    Momtaz, Parisa
    Shoushtari, Alexander Noor
    Wolchok, Jedd D.
    Postow, Michael A.
    Warner, Allison Betof
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Quality of life and symptomatic outcome three to five years after laparoscopic Toupet fundoplication in gastroesophageal reflux disease patients with impaired esophageal motility
    Granderath, FA
    Kamolz, T
    Schweiger, UM
    Pasiut, M
    Wykypiel, H
    Pointner, R
    AMERICAN JOURNAL OF SURGERY, 2002, 183 (02): : 110 - 116
  • [25] Postural and Chronological Change in Pelvic Tilt Five Years After Total Hip Arthroplasty in Patients With Developmental Dysplasia of the Hip: A Three-Dimensional Analysis
    Suzuki, Haruka
    Inaba, Yutaka
    Kobayashi, Naomi
    Ishida, Takashi
    Ike, Hiroyuki
    Saito, Tomoyuki
    JOURNAL OF ARTHROPLASTY, 2016, 31 (01): : 317 - 322
  • [26] Does interruption of imatinib (IM) in responding patients after three years of treatment influence outcome of patients with advanced GIST included in the BFR14 trial?
    Adenis, A.
    Cassier, P. A.
    Bui, B. N.
    Rios, M.
    Duffaud, F.
    Bertucci, F.
    Chabaud, S.
    Perol, D.
    Blay, J. Y.
    Le Cesne, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Incidence and epidemiology of invasive fungal diseases in patients after allogeneic hematopoietic stem cell transplantion receiving antifungal prophylaxis: a five years single-center experience
    Moehrke, Julia
    Wagner-Drouet, Eva Maria
    Theobald, Matthias
    Radsak, Markus Philipp
    Teschner, Daniel
    BONE MARROW TRANSPLANTATION, 2018, 53 : 562 - 563
  • [28] The survival benefit of extensive upper abdominal cytoreduction to optimal residual disease remains significant after five years of follow-up in patients with advanced ovarian cancer
    Eisenhauer, E. L.
    Leitao, M. M.
    Abu-Rustum, N. R.
    Sonoda, Y.
    Brown, C. L.
    Barakat, R. R.
    Chi, D. S.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S59 - S60
  • [29] The Incidence of Chronic Kidney Disease Three Years after Non-Severe Acute Kidney Injury in Critically Ill Patients: A Single-Center Cohort Study
    Rubin, Sebastien
    Orieux, Arthur
    Clouzeau, Benjamin
    Rigothier, Claire
    Combe, Christian
    Gruson, Didier
    Boyer, Alexandre
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [30] Continuous versus interruption of imatinib (IM) in responding patients with advanced GIST after three years of treatment: A prospective randomized phase III trial of the French Sarcoma Group
    Le Cesne, A.
    Ray-Coquard, I.
    Bui, B.
    Rios, M.
    Adenis, A.
    Bertucci, F.
    Duffaud, F.
    Branchu, V. Bourne
    Perol, D.
    Blay, J. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)